证券代码：920476 证券简称：海能技术 公告编号：2025-135 海能未来技术集团股份有限公司 拟进行对外投资的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、对外投资概述 （一）基本情况 根据海能未来技术集团股份有限公司（以下简称"公司"）发展规划，为了 不断丰富公司产品矩阵，布局科学仪器行业中市场空间和增长潜力巨大的质谱产 品，公司拟通过以现金方式认缴新增注册资本及收购原股东部分股权的方式投资 安益谱（苏州）医疗科技有限公司（以下简称"安益谱"），并已于 2025 年 11 月 11 日与安益谱及其股东张小华、王延军、杨锋博、黄健签署了《意向协议书》。 公司本次拟以现金 7,000,000.00 元受让安益谱原股东 1.6393%的股权（对 应注册资本为 138,348.00 元），同时，拟以现金 14,000,000.00 元出资，认缴其 新增注册资本 193,688.00 元，其中 193,688.00 元计入注册资本，13,806,312.00 元计入资本公积。如本次交易顺利完 ...

Group 1 - The core viewpoint of the article highlights the growth in the instrument manufacturing industry in China, with an increase in the number of enterprises and a positive year-on-year growth rate [1] Group 2 - As of January to September 2025, the number of instrument manufacturing enterprises reached 7,662, an increase of 423 compared to the same period last year, representing a year-on-year growth of 5.84% [1] - The instrument manufacturing sector accounts for 1.47% of the total industrial enterprises in China [1] - The data indicates a significant trend in the industry, with the threshold for scale enterprises raised from an annual main business income of 5 million to 20 million yuan since 2011 [1]

Core Viewpoint - The manufacturing sector in China has shown growth in the number of enterprises, with a total of 486,457 companies reported from January to September 2025, marking an increase of 15,226 companies or a year-on-year growth of 3.23% [1] Group 1: Manufacturing Sector Overview - The number of manufacturing enterprises has increased to 486,457 as of January to September 2025, compared to the same period last year [1] - This growth represents a year-on-year increase of 3.23%, indicating a positive trend in the manufacturing industry [1] - Manufacturing enterprises account for 93.11% of the total industrial enterprises, highlighting their significant role in the industrial landscape [1] Group 2: Industry Insights - The data is sourced from the National Bureau of Statistics and compiled by Zhiyan Consulting, a leading industry consulting firm in China [1] - Zhiyan Consulting specializes in providing in-depth industry research reports, business plans, feasibility studies, and customized services, emphasizing its expertise in the field [1] - The report titled "Analysis of the Competitive Landscape and Investment Development Research of China's Manufacturing Industry from 2025 to 2031" offers insights into future trends and investment opportunities [1]

上市公司：创远信科（831961），奥迪威（832491），同惠电子（833509），海能技术（430476），新 芝生物（430685），基康仪器（830879），天罡股份（832651），驰诚股份（834407），莱赛激光 （871263） 相关报告：智研咨询发布的《2025-2031年中国仪器仪表市场供需预测及未来发展趋势报告》 2019年-2025年1-9月全国仪器仪表制造业出口货值统计图 数据来源：国家统计局，智研咨询整理 知前沿，问智研。智研咨询是中国一流产业咨询机构，十数年持续深耕产业研究领域，提供深度产业研 究报告、商业计划书、可行性研究报告及定制服务等一站式产业咨询服务。专业的角度、品质化的服 务、敏锐的市场洞察力，专注于提供完善的产业解决方案，为您的投资决策赋能。 根据国家统计局数据可知：2025年9月全国仪器仪表制造业出口货值为144.4亿元，同比下降2.7%；2025 年1-9月全国仪器仪表制造业累计出口货值为1247.6亿元，累计同比增长8.1%。 ...

Group 1: Market Overview - The recent volatility in the US stock market has raised concerns about a potential new round of market correction, with the Nasdaq dropping by 2% on November 4 and significant declines in Japanese and Korean markets [2][11] - The tightening of dollar liquidity due to the US government shutdown has been identified as a catalyst for increased market fluctuations, with the Treasury General Account (TGA) rising by $200 billion since October [11] Group 2: North Exchange Market Analysis - The North Exchange's Q3 report shows a revenue growth of 5.3% year-on-year, but net profit decreased by 5.0%, indicating ongoing profitability challenges [10][12] - The return on equity (ROE) improved slightly to 6.1%, with asset turnover at 62.0% and net profit margin at 5.6% [10][12] Group 3: Investment Opportunities in Specific Sectors - The industrial automation sector is highlighted as a growth area, with the company achieving market share increases in low-voltage frequency converters and servo systems from 1.80% and 0.55% in 2019 to 3.02% and 2.30% by 2024 [19] - The human-shaped robot industry is also noted for its potential, with the company leveraging its automation technology to reduce R&D cycles and costs [19][20] Group 4: Pharmaceutical Sector Performance - The pharmaceutical sector reported a total revenue of 18,064 billion yuan in the first three quarters of 2025, with a slight year-on-year decline of 1.9% [21][24] - The innovative drug segment showed a significant revenue increase of 36% in Q3, indicating strong growth potential [21][24]

Overall Insights - In the first three quarters of 2025, 53% of the companies in the North Exchange technology growth sector reported positive net profit growth [11][12][15] - The median revenue of the electronic equipment sector was 229 million yuan, reflecting a year-on-year increase of 16.50%, while the median net profit decreased by 7.58% [17][18] - The median revenue of the machinery equipment sector was 204 million yuan, with a year-on-year increase of 7.63%, and the median net profit increased by 6.22% [27][32] - The median revenue of the automotive sector was 385 million yuan, showing a year-on-year increase of 2.49%, and the median net profit increased by 5.01% [5][44] - The median revenue of the new energy sector was 729 million yuan, with a year-on-year increase of 3.68%, while the median net profit decreased by 33.37% [7][25] Electronic Equipment Sector - Among 46 companies in the electronic equipment sector, 18 reported positive growth in both revenue and net profit in Q1-Q3 2025 [25][26] - Key growth drivers included product structure optimization and increased market competitiveness due to R&D investments and government support policies [25][26] Machinery Equipment Sector - The machinery equipment sector showed signs of stabilization, with 7 companies reporting positive growth in both revenue and net profit in Q1-Q3 2025 [30][31] - Growth was attributed to increased demand for core products and successful market expansion efforts [30][31] Automotive Sector - The automotive sector demonstrated consistent revenue growth, with 11 companies reporting positive growth in both revenue and net profit in Q1-Q3 2025 [5][44] - Companies like 旺成科技 and 捷众科技 expanded their market presence and diversified their product offerings, contributing to their revenue growth [5][6] New Energy Sector - In the new energy sector, only 4 out of 19 companies reported positive growth in both revenue and net profit in Q1-Q3 2025 [7][25] - Companies like 酉立智能 and 长虹能源 achieved significant revenue growth due to effective market expansion and product competitiveness [7][25]

Core Viewpoint - The information disclosure requirements for A-share listed companies are becoming increasingly stringent, with the Beijing Stock Exchange (BSE) releasing its first evaluation results for 2024-2025, indicating an overall improvement in disclosure quality among listed companies [2][4]. Summary by Categories Evaluation Results - Among the 262 companies evaluated, 48 received an A rating (18.3%), 178 received a B rating (67.9%), 31 received a C rating (11.8%), and 5 received a D rating (1.9%) [2][4]. - A total of 86.2% of the companies were rated either A or B, indicating a positive trend in information disclosure [4]. Company Performance - The five companies rated D, including Tianye Co. (BJ920023) and Digital People (BJ920670), may face delisting warnings due to issues with their financial report disclosures [2][5]. - The average market capitalization of the 48 A-rated companies is 4.591 billion, with an average stock price increase of 84% this year and an average net profit growth of 28% [14][15]. Regulatory Framework - The BSE's evaluation is part of a broader effort to establish a unified and normalized regulatory framework for information disclosure across China's three major stock exchanges [7]. - The evaluation focuses on three main dimensions: the standardization and effectiveness of information disclosure, investor relations maintenance, and social responsibility disclosure [4]. Impact on Corporate Actions - Companies rated A will receive support and facilitation for refinancing and mergers, including reduced inquiry rounds and targeted training [9]. - Conversely, companies rated D will face increased scrutiny and guidance to improve their information disclosure practices [9]. Notable Company Statistics - In the top 10 companies by market capitalization, 5 received A ratings and 5 received B ratings, indicating a correlation between disclosure quality and market performance [10]. - The top 10 companies by net profit for the first three quarters include 3 A-rated and 7 B-rated companies, further illustrating the relationship between disclosure ratings and financial performance [12][13].

Investment Rating - The investment rating for the company is "Buy" (maintained) [2][4] Core Insights - The company reported a revenue of 227 million yuan for Q1-Q3 2025, representing a year-on-year growth of 23.54%. The net profit attributable to the parent company was 18.11 million yuan, a significant recovery from a loss of 4.68 million yuan in the same period of 2024. The company is expected to maintain strong growth in net profit for 2025-2027, with projections of 47 million yuan, 53 million yuan, and 64 million yuan respectively, corresponding to EPS of 0.55, 0.62, and 0.75 yuan per share [4][6] Financial Performance Summary - For 2025, the company is projected to achieve a revenue of 376 million yuan, with a year-on-year growth of 21.2%. The net profit is expected to be 47 million yuan, reflecting a substantial increase of 258.3% compared to 2024. The gross margin is forecasted to be 65.1%, and the net margin is expected to be 10.8% [6][9] - The company's total assets are estimated to be 610 million yuan in 2025, with total liabilities of 110 million yuan, resulting in a debt-to-asset ratio of approximately 18.1% [8][9] Industry Overview - The scientific instrument industry is crucial for high-quality economic development and technological innovation, with applications across various sectors including food, pharmaceuticals, agriculture, environmental monitoring, and new energy. The industry experienced a revenue growth of 7.0% year-on-year, reaching 509.42 billion yuan in the first half of 2025, with total profits amounting to 49.25 billion yuan, a year-on-year increase of 9.2% [6][8]

证券代码：920476 证券简称：海能技术 公告编号：2025-134 海能未来技术集团股份有限公司 投资者关系活动记录表 □现场参观 □新闻发布会 □分析师会议 □路演活动 √其他 （线上会议） 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 一、 投资者关系活动类别 □特定对象调研 □业绩说明会 □媒体采访 二、 投资者关系活动情况 活动时间：2025 年 10 月 28 日 活动地点：线上调研 参会单位及人员：第一场：华源证券、创金合信基金、天弘基金、前海联合 基金、同泰基金、嘉合基金、开源证券、兴业证券、申万宏源证券、中泰证券、 长江证券、国投证券、红塔证券、民生证券、联储证券、上海东方证券资产管理 有限公司、上海艾叶私募基金管理有限公司、上海易正朗投资管理有限公司、深 圳市尚诚资产管理有限责任公司、鸿运私募基金管理(海南)有限公司、磊垚资本、 洪顺资本、巨鹿投资、上海冰河资产管理有限公司、深圳市正德泰投资有限公司、 北京星允投资管理有限公司、明河投资、浦赢建和（上海）资产管理有限公司。 第二场 ...

Investment Rating - The report maintains a rating of "Outperform" for the company [6][9]. Core Insights - The company reported a revenue of 227 million yuan for the first three quarters of 2025, representing a year-on-year increase of 23.5%. The net profit attributable to the parent company was 18 million yuan, marking a return to profitability [6]. - In Q3 2025, the company achieved a revenue of 91 million yuan, up 9.8% year-on-year, with a net profit of 13 million yuan, reflecting a 35.3% increase [6]. - The report highlights that the company's revenue growth is driven by the high demand for its chromatography and spectroscopy series, despite a high base effect from the previous year [9]. - The gross margin for Q3 2025 was 63.0%, slightly down by 1.2 percentage points year-on-year, attributed to a higher proportion of lower-margin products [9]. - The report emphasizes the growth potential in the domestic high-end scientific instrument market, supported by government policies and increasing research and testing demands [9]. - The company is expected to benefit from a clear long-term growth momentum, with strong product launches and a broad customer base [9]. Financial Data and Profit Forecast - The total revenue forecast for 2025 is 378 million yuan, with a projected growth rate of 21.9% [8]. - The net profit attributable to the parent company is expected to reach 45 million yuan in 2025, with a significant year-on-year growth of 246.6% [8]. - The report projects a steady increase in earnings per share, estimating 0.53 yuan per share for 2025 [8]. - The company's price-to-earnings ratio is forecasted to be 51 for 2025, decreasing to 31 by 2027 [8].